ezetimibe has been researched along with Fibrosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, K; Honda, M; Kaneko, S; Kato, K; Kita, Y; Misu, H; Mizukoshi, E; Nakamura, M; Ota, T; Sunagozaka, H; Takamura, T; Takeshita, Y; Yamada, K; Yamashita, T; Zen, Y | 1 |
| Guo, Y; Liang, Y; Liu, S; Ren, Q; Wang, X; Wu, T | 1 |
| Fujii, H; Kawada, N; Ogawa, T; Yoshizato, K | 1 |
| Acton, S; Braun, A; Broschat, KO; Krieger, M; Krul, ES; Napawan, N; Stagliano, N; Yesilaltay, A | 1 |
1 trial(s) available for ezetimibe and Fibrosis
| Article | Year |
|---|---|
The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial.
Topics: Aged; Anticholesteremic Agents; Area Under Curve; Azetidines; Biopsy; Carnitine; Cholesterol; Ezetimibe; Fatty Acids; Female; Fibrosis; Gene Expression Profiling; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Liver; Male; Middle Aged; Myofibroblasts; Non-alcoholic Fatty Liver Disease; Oligonucleotide Array Sequence Analysis; Signal Transduction; Transaminases; Treatment Outcome | 2014 |
3 other study(ies) available for ezetimibe and Fibrosis
| Article | Year |
|---|---|
Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.
Topics: Acetyl-CoA Carboxylase; Animals; Anticholesteremic Agents; Azetidines; CD36 Antigens; Diet, High-Fat; Ezetimibe; Fatty Acids; Fibrosis; Hyperinsulinism; Insulin Resistance; Lipid Metabolism; Lipogenesis; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Stearoyl-CoA Desaturase | 2014 |
A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Azetidines; Cholesterol, Dietary; Diet; Dietary Fats; Disease Models, Animal; Ezetimibe; Fatty Liver; Fibrosis; Gene Expression Profiling; Glucose; Humans; Liver; Male; Microarray Analysis; Molecular Sequence Data; Oxidative Stress; Rabbits | 2010 |
Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Azetidines; Bile Acids and Salts; Body Weight; Cardiomegaly; Cholesterol; Coronary Artery Disease; Cyclic N-Oxides; Disease Models, Animal; Eating; Ezetimibe; Female; Fibrosis; Hypercholesterolemia; Intestinal Absorption; Life Expectancy; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Scavenger Receptors, Class B; Survival Rate; Triglycerides; Tropanes | 2008 |